Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.
Richardson PG, Weller E, Lonial S, Jakubowiak AJ, Jagannath S, Raje NS, Avigan DE, Xie W, Ghobrial IM, Schlossman RL, Mazumder A, Munshi NC, Vesole DH, Joyce R, Kaufman JL, Doss D, Warren DL, Lunde LE, Kaster S, Delaney C, Hideshima T, Mitsiades CS, Knight R, Esseltine DL, Anderson KC. Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma. Blood. 2010 Aug 05; 116(5):679-86.
-
Paul Gerard Guy Richardson, M.B.,B.S.
-
Kenneth Carl Anderson, M.D.
-
Robin Marie Joyce, M.D.
-
Irene Ghobrial, M.D.
-
Edie A. Weller Toolan, Ph.D.
-
Noopur Raje, M.D.
-
Nikhil C Munshi, M.D., M.B.,B.S.
-
Constantine S Mitsiades, Ph.D., M.D.
-
Teru Hideshima, Ph.D., M.D.
-
David E. Avigan, M.D.